Bioactivity | Lunsekimig is an anti-TSLP/IL13/ALB monoclonal antibody composed of 5 sequentially linked variable region heavy chains[1]. |
Target | TSLP/IL13/ALB |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Lunsekimig |